Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock

NCT00420030 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Shock, Cardiogenic

Interventions

DRUG: Abciximab

Sponsor

Charles University, Czech Republic

Collaborators

[object Object]